Baseline characteristics, including age, gender, ECOG PS, primary tumor sidedness, metastatic sites, RAS/BRAF and MMR status, comorbidities, prior adjuvant therapy, radiotherapy, and neoadjuvant therapy for rectal cancer, are summarized in Table 1. Here, BRAF is linked to rectal cancer.